Yoon Ha Hwang

Dr. Yoon Ha Hwang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YJYou Hoon Jeon
You Hoon Jeon
KAKangmo Ahn
Kangmo Ahn
JKJihyun Kim
Jihyun Kim
MSMeeyong Shin
Meeyong Shin
SHSoo-Jong Hong
Soo-Jong Hong
RDRespiratory Disease
Respiratory Disease
Jeon YH, et al. J Korean Med Sci. 2022 Jan;37(4):e30. https://doi.org/10.3346/jkms.2022.37.e30

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
CKChang-Keun Kim
Chang-Keun Kim
YHYoon Ha Hwang
Yoon Ha Hwang
DSDae Jin Song
Dae Jin Song
JYJinho Yu
Jinho Yu
MSMyung Hyun Sohn Sohn
Myung Hyun Sohn Sohn
YRYeong-Ho Rha
Yeong-Ho Rha
Kim CK, et al. Allergy Asthma Immunol Res. 2024 Nov;16(6):652-667. https://doi.org/10.4168/aair.2024.16.6.652

1 January 2017 in Allergy Asthma & Respiratory Disease
Verified
Journal Article
Open access
PDF file
YHYoon Ha Hwang
Yoon Ha Hwang
JKJoon Seok Kang
Joon Seok Kang
BKByoung Kuk Kim
Byoung Kuk Kim
SKSung Won Kim
Sung Won Kim
Hwang Y, et al. Allergy Asthma Respir Dis. 2017 Jan;5(1):21-26. https://doi.org/10.4168/aard.2017.5.1.21

15 September 2024 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
ELEun Lee
Eun Lee
KKKyunghoon Kim
Kyunghoon Kim
YJYou Hoon Jeon
You Hoon Jeon
ISIn Suk Sol
In Suk Sol
JKJong Deok Kim
Jong Deok Kim
GJGwang Cheon Jang
Gwang Cheon Jang
Noncystic fibrosis bronchiectasis is a chronic respiratory disease that carries high socioeconomic and medical burdens and is caused by diverse respiratory illnesses. To improve clinical outcomes, early recognition, active treatment of exacerbations, and prevention of further exacerbations are essential. However, evidence for the treatment and prevention of acute exacerbation of noncystic fibrosis bronchiectasis, especially in children, is lacking. Therefore, the evidence- and consensus-based guidelines for medical and nonmedical treatment strategies for noncystic fibrosis bronchiectasis in children and adolescents were developed by the Korean Academy of Pediatric Allergy and Respiratory Disease using the methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation working group with evidence published through July 2, 2020. This guideline encompasses evidence-based treatment recommendations as well as expert opinions, addressing crucial aspects of the treatment and management of non-cystic fibrosis bronchiectasis in children. This includes considerations for antibiotics and airway clearance strategies, particularly in areas where evidence may be limited. Large, well-designed, and controlled studies are required to accumulate further evidence of management strategies for noncystic fibrosis bronchiectasis in children and adolescents.

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
YHYoon Ha Hwang
Yoon Ha Hwang
JKJihyun Kim
Jihyun Kim
KAKangmo Ahn
Kangmo Ahn
KJKyunguk Jeong
Kyunguk Jeong
SLSooyoung Lee
Sooyoung Lee
RDRespiratory Disease
Respiratory Disease
Hwang Y, et al. Allergy Asthma Immunol Res. 2024 Sep;16(5):555-561. https://doi.org/10.4168/aair.2024.16.5.555

1 January 2025 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
MKMinji Kim
Minji Kim
JLJi Young Lee
Ji Young Lee
SLSooyoung Lee
Sooyoung Lee
KJKyunguk Jeong
Kyunguk Jeong
MSMeeyong Shin
Meeyong Shin
JKJihyun Kim
Jihyun Kim
Kim M, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):127-134. https://doi.org/10.4168/aair.2025.17.1.127